Janus Henderson Group PLC Point Biopharma Global Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.67 - $9.71 $663,985 - $966,611
99,548 Added 34.12%
391,264 $2.61 Million
Q2 2023

Aug 14, 2023
BUY
$6.86 - $10.86 $1.8 Million - $2.85 Million
262,162 Added 887.06%
291,716 $2.64 Million
Q1 2023

May 15, 2023
BUY
$6.78 - $8.1 $105,876 - $126,489
15,616 Added 112.04%
29,554 $214,000
Q4 2022

Feb 14, 2023
BUY
$5.72 - $9.78 $79,725 - $136,313
13,938 New
13,938 $101,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email